During the past decade, HD Research conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 7 clinical trials were completed, i.e. on average, 29.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 5 clinical trials were completed. i.e. 29.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HD Research" #1 sponsor was "InGeneron, Inc." with 3 trials, followed by "Concentric Analgesics" with 2 trials sponsored, "Haisco-USA Pharmaceuticals, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Pacira Pharmaceuticals, Inc" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HD Research" #1 collaborator was "Allucent" with 1 trials as a collaborator, "Sanford Health" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "HD Research" are "Acute Pain" (3 trials), "Influenza" (2 trials), "Pain" (2 trials), "Pain, Postoperative" (2 trials) and "Abdominoplasty" (1 trials). Many other conditions were trialed in "HD Research" in a lesser frequency.

Most popular intervention types in "HD Research" are "Drug" (21 trials), "Device" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Bupivacaine Hydrochloride" (3 trials), "Acetaminophen" (2 trials), "Adipose Derived Regenerative Cells" (2 trials) and "Baloxavir Marboxil" (2 trials). Other intervention names were less common.

The vast majority of trials in "HD Research" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "HD Research". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in HD Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HD Research, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".